Trial intelligence / Profile preview

Ultrasound-guided superficial cervical plexus block for recovery after thyroidectomy

ACTRN12616001628437Phase 4Completed

Sponsor
Yanqing Chen
Start
Jan 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in thyroid disease (2 arms), sponsored by Yanqing Chen. Primary endpoint: Quality of recovery. Started Jan 2017; status: completed.

02

Drugs

ropivacaine
03

Conditions

thyroid disease

Beyond the preview

Go deeper on ACTRN12616001628437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616001628437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call